Victor Golmer
After launching its Wegovy pill early this month, Novo Nordisk (NVO) has garnered 3,071 U.S. prescriptions for the oral GLP-1 agonist in the first four days of its commercial rollout, … [+74 chars]
Novo Nordisk wins 3,071 prescriptions for Wegovy pill (NVO:NYSE) - Seeking Alpha
Novo Nordisk (NVO) stock is in focus as the Wegovy pill tops 3,071 U.S. scripts in the first 4 days of its launch. Read more here.
By:Dulan Lokuwithana
Source:Seeking Alpha
Published:
Related News
Trump Tariff Threats Weigh on Asian Risk Appetite: Markets Wrap - Bloomberg.com
European and US stock futures fell and haven assets such as gold rallied after President Donald Trump proposed new levies on eight countries that have opposed his plans to acquire Greenland. The dollar weakened against most of its major peers.
Bloomberg•Anand Krishnamoorthy
Trump Tariff Threat to Weigh on Risk Sentiment, European Stocks - Bloomberg.com
US President Donald Trump’s announcement of new tariffs on eight European countries over Greenland weighed on risk sentiment as trading kicked off Monday.
Bloomberg•Farah Elbahrawy, Julien Ponthus
Sequoia to invest in Anthropic, breaking VC taboo on backing rivals: FT - TechCrunch
Sequoia Capital is reportedly joining a blockbuster funding round for Anthropic, the AI startup behind Claude, according to the Financial Times. It's a
TechCrunch•Connie Loizos